Pakistan to start Covid-19 vaccination drive next week
Last week, the country approved the emergency use of the Oxford-AstraZeneca Covid-19 vaccine28-01-2021
28-01-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dated January 1, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.27-01-2021
Nepal kicks off coronavirus inoculations with Indian vaccine
Tens of thousands of Nepal's frontline health workers are set to receive India's AstraZeneca vaccine, caretaker Prime Minister K.P. Sharma Oli said as the drive began.27-01-2021
Pre-produced Covishield, Covaxin in 6-month race against expiry
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months26-01-2021
Send all pre-paid doses of AstraZeneca despite plans to delay supply: EU
The commissioner stressed that the EU required AstraZeneca to provide a report regarding the company's activities, adding that the bloc would hold the second round of consultations with AstraZeneca26-01-2021
South Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII
The SII doses are intended for South Africa's frontline healthcare workers21-01-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- PRATAP RUDRADesignation :- Company Secretary and Compliance Officer21-01-2021
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Shareholding for the Period Ended December 31, 2020
AstraZeneca Pharma India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here20-01-2021
Coronavirus News LIVE Updates: India to start exporting Oxford-AstraZeneca COVID-19 vaccines from today
Coronavirus News LIVE Updates: India's COVID-19 tally stands at more than 1.05 crore, including 1.52 lakh deaths. India will start exporting COVID-19 vaccines from today, paving the way for many mid and lower-income countries to get supplies of the easy-to-store Oxford/AstraZeneca drug.20-01-2021
Pakistan approves emergency use of Oxford-AstraZeneca Covid-19 vaccine
Pakistan has approved the emergency use of Oxford-AstraZeneca Covid-19 vaccine and the government hopes to make the drug available by the first quarte17-01-2021